Log In / Sign Up

HB 665

  • Tennessee House Bill
  • 113th Regular Session (2023-2024)
  • Introduced in House Jan 30, 2023
  • House
  • Senate
  • Governor

Opioids - As introduced, prohibits a healthcare provider from prescribing a buprenorphine product unless the patient has first signed a copy of an informational document on the risks of buprenorphine use to pregnant women, unborn children, and infants; requires the department of health to make available on its public website the informational document within 90 days of the effective date of the act. - Amends TCA Title 53 and Title 63.

View Latest Bill Text
Sign In to Follow

Bill Subjects

Opioids

Abstract

Bill Sponsors (1)

Tim Hicks

  • Republican
  • Representative
  • District 6
Primary

Votes

No votes to display

Actions

Feb 01, 2023

House

Assigned to s/c Health Subcommittee

House

P2C, ref. to Health Committee

Jan 30, 2023

House

Intro., P1C.

Jan 26, 2023

House

Filed for introduction

Bill Text

Bill Text Versions Format
Current Version PDF

Related Documents

Document Format
Fiscal Note

Sources

Data on Open States is updated periodically throughout the day from the official website of the Tennessee General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.